BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  December 6, 2024

   · 

  2 min read
• Press Releases

  eClinical Solutions Market Size Expected to Hit USD 35.01 Billion by 2034

  December 6, 2024

   · 

  1 min read
• Press Releases

  Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

  December 6, 2024

   · 

  1 min read
• Press Releases

  U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health’s Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins

  December 6, 2024

   · 

  6 min read
• Press Releases

  AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment

  December 6, 2024

   · 

  1 min read
• Press Releases

  Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

  December 6, 2024

   · 

  6 min read
• Press Releases

  NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

  December 6, 2024

   · 

  2 min read
• Press Releases

  Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)

  December 6, 2024

   · 

  6 min read
• Press Releases

  Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

  December 6, 2024

   · 

  7 min read
• Press Releases

  Protara Announces Positive Results from the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

  December 6, 2024

   · 

  8 min read